Funder: METAvivor
Due Dates: Letter of Intent: March 12, 2025 | Internal Submission: August 20, 2025 | Application Deadline: December 30, 2025
Funding Amounts: $200,000 total over 2 years for early career investigators
Summary: Supports innovative research by early career investigators to advance treatment and understanding of metastatic breast cancer.
Key Information: Proposals must focus on established breast cancer metastases with clear patient relevance; prevention or general diagnosis studies are not eligible.